Addus HomeCare (NASDAQ:ADUS) Cut to “Underweight” at Barclays

Barclays cut shares of Addus HomeCare (NASDAQ:ADUS) from an equal weight rating to an underweight rating in a research note released on Tuesday morning, MarketBeat reports. They currently have $83.00 price target on the stock.

Other equities analysts also recently issued reports about the stock. Oppenheimer restated an outperform rating and set a $118.00 price objective on shares of Addus HomeCare in a research note on Tuesday, March 26th. William Blair reaffirmed an outperform rating on shares of Addus HomeCare in a research report on Monday, February 5th. Finally, Royal Bank of Canada reissued an outperform rating and issued a $102.00 price objective on shares of Addus HomeCare in a report on Thursday, February 29th. One analyst has rated the stock with a sell rating and seven have issued a buy rating to the stock. According to MarketBeat.com, Addus HomeCare currently has an average rating of Moderate Buy and a consensus price target of $103.00.

Addus HomeCare Stock Up 3.1 %

NASDAQ:ADUS opened at $94.54 on Tuesday. The company has a market cap of $1.53 billion, a PE ratio of 24.62, a PEG ratio of 1.88 and a beta of 0.96. The stock has a 50-day simple moving average of $97.69 and a 200 day simple moving average of $91.59. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.38 and a current ratio of 1.38. Addus HomeCare has a 52-week low of $77.30 and a 52-week high of $114.97.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings data on Monday, February 26th. The company reported $1.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.04 by $0.17. Addus HomeCare had a net margin of 5.91% and a return on equity of 9.70%. The company had revenue of $276.35 million for the quarter, compared to the consensus estimate of $274.02 million. On average, sell-side analysts expect that Addus HomeCare will post 4.38 EPS for the current fiscal year.

Institutional Trading of Addus HomeCare

Several hedge funds have recently added to or reduced their stakes in ADUS. TimesSquare Capital Management LLC lifted its holdings in shares of Addus HomeCare by 55.0% during the 3rd quarter. TimesSquare Capital Management LLC now owns 233,758 shares of the company’s stock worth $19,914,000 after acquiring an additional 82,920 shares during the period. Allianz Asset Management GmbH acquired a new stake in shares of Addus HomeCare in the 4th quarter valued at $5,667,000. Vanguard Group Inc. increased its stake in shares of Addus HomeCare by 4.9% in the 3rd quarter. Vanguard Group Inc. now owns 1,218,564 shares of the company’s stock valued at $103,809,000 after purchasing an additional 57,040 shares during the last quarter. Jacobs Levy Equity Management Inc. raised its holdings in shares of Addus HomeCare by 127.7% during the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 100,158 shares of the company’s stock worth $8,532,000 after buying an additional 56,171 shares in the last quarter. Finally, Assenagon Asset Management S.A. lifted its position in shares of Addus HomeCare by 78.8% during the 1st quarter. Assenagon Asset Management S.A. now owns 112,256 shares of the company’s stock worth $11,601,000 after buying an additional 49,483 shares during the last quarter. 95.35% of the stock is owned by institutional investors and hedge funds.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.